Literature DB >> 14708592

The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders.

Michael P Schön1, Thomas M Zollner, W Henning Boehncke.   

Abstract

Spatial compartmentalization and tissue-selective localization of T lymphocytes to the skin are crucial for immune surveillance and the pathogenesis of various disorders including common inflammatory diseases such as atopic dermatitis or psoriasis, but also malignancies such as cutaneous T cell lymphomas. Cutaneous recruitment of lymphocytes is a highly complex process that involves extravasation, migration through the dermal connective tissue, and eventually, localization to the epidermis. An intertwined network of cytokines and chemokines provides the road signs for leukocyte migration, while various adhesion receptors orchestrate the dynamic events of cell-cell and cell-substrate interactions resulting in cutaneous localization of T cells. Selectively targeting the functions of molecules involved in this interplay promises exciting new therapeutic options for treating inflammatory skin disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708592     DOI: 10.1046/j.1523-1747.2003.12563.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  25 in total

1.  Selectin and selectin ligand binding: a bittersweet attraction.

Authors:  Thomas M Zollner; Khusru Asadullah
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 2.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 3.  Skin-Associated B Cells in Health and Inflammation.

Authors:  Gudrun F Debes; Shannon E McGettigan
Journal:  J Immunol       Date:  2019-03-15       Impact factor: 5.422

4.  The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.

Authors:  C de O Mendes-Aguiar; A Gomes-Silva; E Nunes; R Pereira-Carvalho; R S Nogueira; M de P Oliveira-Neto; A L Bertho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

5.  Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models.

Authors:  Susann Forkel; Margarete Schön; Annette Hildmann; Anna Claßen; Swen-Malte John; Kerstin Danker; Michael P Schön
Journal:  J Invest Dermatol       Date:  2014-04-08       Impact factor: 8.551

6.  Lesional skin chemokine CTACK/CCL27 expression in mycosis fungoides and disease control by IFN-alpha and PUVA therapy.

Authors:  Gaia Goteri; Serena Rupoli; Anna Campanati; Antonello Costagliola; Simona Sabato; Daniela Stramazzotti; Paola Picardi; Lucia Canafoglia; Stefano Pulini; Giulia Ganzetti; Anna Maria Offidani; Pietro Leoni
Journal:  Am J Transl Res       Date:  2009-01-31       Impact factor: 4.060

Review 7.  The genetics of atopic dermatitis.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

8.  Effects of plant alkylphenols on cytokine production, tyrosine nitration and inflammatory damage in the efferent phase of contact hypersensitivity.

Authors:  A Olmos; R M Giner; M C Recio; J L Rios; J M Cerdá-Nicolás; S Máñez
Journal:  Br J Pharmacol       Date:  2007-07-30       Impact factor: 8.739

9.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

10.  The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis.

Authors:  Joanna Narbutt; Aleksandra Lesiak; Anna Sysa-Jedrzeiowska; Marcin Zakrzewski; Jarosław Bogaczewicz; Iwona Stelmach; Piotr Kuna
Journal:  Mediators Inflamm       Date:  2009-07-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.